AD

Gilteritinib hemifumarate(CAS: 1254053-84-3)

Gilteritinib hemifumarate
CAS Number

Related Products

Other Suppliers for Gilteritinib hemifumarate

Basic Information

Molecular Formula
C62H92N16O10
Molecular Weight
1221.5 g/mol

Chemical Identifiers

SMILES
OC(=O)/C=C/C(=O)O.COc1cc(ccc1N1CCC(CC1)N1CCN(CC1)C)Nc1nc(NC2CCOCC2)c(nc1C(=O)N)CC.COc1cc(ccc1N1CCC(CC1)N1CCN(CC1)C)Nc1nc(NC2CCOCC2)c(nc1C(=O)N)CC
InChIKey
UJOUWHLYTQFUCU-WXXKFALUSA-N

Database References

MDL Number
MFCD28386208

FAQ

Gilteritinib hemifumarate is a prodrug that is converted to gilteritinib, an inhibitor of the FLT3 receptor tyrosine kinase. It is used in the treatment of acute myeloid leukemia (AML) with a FLT3 mutation.
Gilteritinib hemifumarate is primarily used in the treatment of patients with acute myeloid leukemia (AML) who have a mutation in the FLT3 gene. It is also used in clinical trials for the treatment of other hematologic malignancies.
Gilteritinib hemifumarate is generally considered safe when used as directed. However, it can cause side effects such as nausea, diarrhea, fatigue, and certain blood disorders. Patients should follow medical advice to minimize risks.
Gilteritinib hemifumarate should be stored at room temperature (15-30°C) and protected from light. It should be kept in a tightly closed container and away from moisture and heat to maintain its effectiveness and stability.

Safety Notice

Please verify product specifications and safety data before use. Contact the supplier for detailed safety information.

Always follow proper handling procedures

Contact Information

Contact Person

Manager Gu

Email

sales@gh-reagent.com

Mobile

18939883912

Telephone

021-34536277

Address

No. 91, Building 2, Block 537, Sanada Road, Minhang District, Pujiang Town, Shanghai